Kucukcelebi, S.; Diepen, A.E.v.; Vos-Geelen, J.d.; van Eijck, C.H.J.; Montfoort, N.v.; Eijck, C.W.F.v.
CD40 Agonism in Pancreatic Ductal Adenocarcinoma: Expression, Biology, and Therapeutic Targeting. Cancers 2026, 18, 1743.
https://doi.org/10.3390/cancers18111743
AMA Style
Kucukcelebi S, Diepen AEv, Vos-Geelen Jd, van Eijck CHJ, Montfoort Nv, Eijck CWFv.
CD40 Agonism in Pancreatic Ductal Adenocarcinoma: Expression, Biology, and Therapeutic Targeting. Cancers. 2026; 18(11):1743.
https://doi.org/10.3390/cancers18111743
Chicago/Turabian Style
Kucukcelebi, Songul, Aniek E. van Diepen, Judith de Vos-Geelen, Casper H. J. van Eijck, Nadine van Montfoort, and Casper W. F. van Eijck.
2026. "CD40 Agonism in Pancreatic Ductal Adenocarcinoma: Expression, Biology, and Therapeutic Targeting" Cancers 18, no. 11: 1743.
https://doi.org/10.3390/cancers18111743
APA Style
Kucukcelebi, S., Diepen, A. E. v., Vos-Geelen, J. d., van Eijck, C. H. J., Montfoort, N. v., & Eijck, C. W. F. v.
(2026). CD40 Agonism in Pancreatic Ductal Adenocarcinoma: Expression, Biology, and Therapeutic Targeting. Cancers, 18(11), 1743.
https://doi.org/10.3390/cancers18111743